New Delhi, June 13 -- Sun Pharmaceutical Industries Ltd's India business head Kirti Ganorkar will succeed founder Dilip Shanghvi as managing director as India's largest drugmaker announced a major leadership rejig on Friday.

Ganorkar will take on his new role effective 1 September 2025, the company said in a release. Shanghvi will continue on as executive chairman to chair the board, and focus on its specialty portfolio and shaping the company's long-term strategy, it said.

"...I have a firm belief in his [Ganorkar's] ability to lead the company into its next phase of growth and extend my best wishes for his success," Dilip Shanghvi said in the statement. "Kirti's elevation showcases our strong in-house talent pool, ensuring continuity ...